Clinical trial
Treatment of Transfusion-dependent Nonsevere Aplastic Anemia With Luspatercept: a Multicenter Prospective Clinical Study
NCT06964971 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Zhejiang Chinese Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Transfusion-dependent Nonsevere Aplastic Anemia With Luspatercept: a Multicenter Prospective Clinical Study
- Lead sponsor
- The First Affiliated Hospital of Zhejiang Chinese Medical University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- May 20, 2025
- Completion date
- June 30, 2027
- Enrollment
- 90 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
transfusion-dependent non-severe aplastic anemia